Malaria Diagnostics Market 2017- Global Industry Analysis, Size, Share, Growth and Forecast Report Up To 2022
According to Stratistics
MRC, the Global Malaria Diagnostics market is accounted for $609.63 million in
2016 and is expected to reach $869.26 million by 2023 growing at a CAGR of
5.2%. Rising demand and increasing need for high-quality and cost-efficient
diagnostic methods, advent of advanced technologies and increasing investment
in research and development of novel therapeutics are some of the key factors
boosting the market growth. However, rising demand for low cost diagnostic
tests and technological complications are limiting the growth of the market.
Malaria is one of the most
widespread life-threatening diseases, commonly occurring in the tropical and
sub-tropical regions. Globally, around 3.2 billion populace still remains at
the increased risk of the disease. As per the WHO estimates, September 2015,
214 million malarial cases were detected in 2015, and the number of fatalities
was estimated to be 438,000 during the same period. Malaria diagnosis is
conducted using various techniques such as molecular diagnostics, rapid
diagnostic tests (RDTs), and by detecting the presence of parasites using
microscopy.
Rapid Diagnostic Tests (RDT)s are mostly used, where microscopy examination is not feasible, especially in remote areas with restricted access to quality microscopy services or poor healthcare infrastructure. In addition, they are user-friendly, provide less turnaround time and need low-skilled labor force. Thus, these factors are expected to be some of the key factors attributed for the growth of the RDT diagnostics at a global level.
Some of the key players in global malaria diagnostics market include Bio-Rad Laboratories, Inc., Wako Chemicals, Inc, Siemens Healthcare, Premier Medical Corporation, Ortho-Clinical Diagnostics, Novartis Diagnostics, Life Technology, Leica Microsystems, BioMérieux, Beckman Coulter/Danaher, Alere Inc., Access Bio Inc., Abbott Laboratories, Sysmex Partec GmbH, Nikon Corporation and Olympus Corporation.
Rapid Diagnostic Tests (RDT)s are mostly used, where microscopy examination is not feasible, especially in remote areas with restricted access to quality microscopy services or poor healthcare infrastructure. In addition, they are user-friendly, provide less turnaround time and need low-skilled labor force. Thus, these factors are expected to be some of the key factors attributed for the growth of the RDT diagnostics at a global level.
Some of the key players in global malaria diagnostics market include Bio-Rad Laboratories, Inc., Wako Chemicals, Inc, Siemens Healthcare, Premier Medical Corporation, Ortho-Clinical Diagnostics, Novartis Diagnostics, Life Technology, Leica Microsystems, BioMérieux, Beckman Coulter/Danaher, Alere Inc., Access Bio Inc., Abbott Laboratories, Sysmex Partec GmbH, Nikon Corporation and Olympus Corporation.
Full report with Table of
Content: https://marketreportscenter.com/reports/571492/malaria-diagnostics-global-market-outlook-2017-2023
Technologies Covered:
Molecular Diagnostics
Rapid Diagnostic Tests (RDT)
Microscopy
Other Technologies
Regions Covered:
North America
o US
o Canada
o Mexico
Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
Molecular Diagnostics
Rapid Diagnostic Tests (RDT)
Microscopy
Other Technologies
Regions Covered:
North America
o US
o Canada
o Mexico
Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment